Related Concept Videos
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Different connectivity patterns of MRI-negative drug-resistant epilepsy and drug-sensitive epilepsy in cerebellar and subcortical-cortical regions.
Neurobiology of disease·2026
Same author
A human case of Q fever associated with cat in China: a neglected risk factor of Q fever.
One health outlook·2026
Same author
Differential predictive value of baseline tumor size according to PD-L1 expression in advanced NSCLC treated with immune checkpoint inhibitors.
Cancer treatment and research communications·2026
Related Experiment Video
Updated: Jun 2, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
CD46 protects against chronic obstructive pulmonary disease.
Sandra Grumelli1, Bao Lu, Leif Peterson
1Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Plos One
|May 17, 2011
Summary
Higher CD46 expression in ex-smokers protects lungs from emphysema and COPD by regulating immune cells and inflammation. This immune regulation prevents necrosis and promotes apoptosis, safeguarding against chronic inflammation and autoimmunity.
Area of Science:
- Immunology
- Pulmonology
- Genetics
Background:
- Chronic obstructive pulmonary disease (COPD) and emphysema affect ex-smokers, with immune system dysfunction implicated in persistent inflammation.
- The specific mechanisms protecting some ex-smokers from developing emphysema remain unclear.
Purpose of the Study:
- To identify protective genes in ex-smokers without emphysema.
- To elucidate the role of CD46 in preventing COPD and emphysema development.
Main Methods:
- Gene expression analysis using microarrays on human lung tissue.
- Validation by quantitative reverse transcription PCR (qRT-PCR) and flow cytometry.
- Murine smoking model to replicate findings and assess complement cascade involvement.
- ELISA to detect anti-elastin antibodies in patient serum.
Main Results:
- Lower CD46 expression correlated with COPD and emphysema; higher CD46 expression was found in protected ex-smokers.
- Decreased CD46(+) cells were associated with reduced CD4(+) T cells, increased CD95, and elevated CD8(+) T cells in COPD patients.
- CD46 regulates T regulatory cells and the complement cascade (C3b degradation).
- Murine models showed increased C5a, suppressed T helper 1 bias, and elastin-C3b complexes, suggesting elastin as a potential antigen.
- Elevated IgG antibodies to elastin were detected in severe early-onset COPD patients.
Conclusions:
- Increased CD46 expression in ex-smokers' lungs confers protection against emphysema and COPD.
- CD46 mitigates inflammation by promoting T regulatory cell production and degrading C3b, thereby restraining the complement cascade.
- This mechanism favors apoptosis over necrosis, protecting against autoimmunity and chronic inflammation.